FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mary Beth DeYoung

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Genes & Molecular Sequences

Devices

Gene Transfer Techniques

Physiology

Co-author Network

Publications

TOP 3
Aaron E Cozen; Hideaki Moriwaki; Michal Kremen; Mary Beth DeYoung; Helén L Dichek; Katherine I Slezicki; Stephen G Young; Murielle Véniant; David A Dichek
Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.
Marten Falkenberg; Clifford Tom; Mary Beth DeYoung; Shan Wen; Ruth Linnemann; David A Dichek
Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth.
Mary Beth DeYoung; C Tom; David A Dichek
Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mary Beth DeYoung (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Aaron E Cozen; Hideaki Moriwaki; Michal Kremen; Mary Beth DeYoung; Helén L Dichek; Katherine I Slezicki; Stephen G Young; Murielle Véniant; David A Dichek
Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.
Circulation 2004;109(17):2129-35.
2002: Marten Falkenberg; Clifford Tom; Mary Beth DeYoung; Shan Wen; Ruth Linnemann; David A Dichek
Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(16):10665-70.
2001: Mary Beth DeYoung; C Tom; David A Dichek
Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries.
Circulation 2001;104(16):1972-1.
2000: Darren B Schneider; G Vassalli; Shan Wen; Robert Driscoll; AB Sassani; Mary Beth DeYoung; Ruth Linnemann; Renu Virmani; David A Dichek
Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(2):298-308.
1999: Mary Beth DeYoung; C Zamarron; A P Lin; C Qiu; Robert Driscoll; David A Dichek
Optimizing vascular gene transfer of plasminogen activator inhibitor 1.
Human gene therapy 1999;10(9):1469-78.
1998: Mary Beth DeYoung; David A Dichek
Gene therapy for restenosis: are we ready?
Circulation research 1998;82(3):306-13.
1996: G Dong; A H Schulick; Mary Beth DeYoung; David A Dichek
Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta1 responsiveness in endothelium in vivo.
The Journal of biological chemistry 1996;271(47):29969-77.